158 related articles for article (PubMed ID: 1714663)
1. Identification of residues in VP2 that contribute to poliovirus neutralization antigenic site 3B.
Reynolds C; Page G; Zhou H; Chow M
Virology; 1991 Sep; 184(1):391-6. PubMed ID: 1714663
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis for linkage of a continuous and discontinuous neutralization epitope on the structural polypeptide VP2 of poliovirus type 1.
Wiegers KJ; Wetz K; Dernick R
J Virol; 1990 Mar; 64(3):1283-9. PubMed ID: 1689392
[TBL] [Abstract][Full Text] [Related]
3. Antigenic structure of polioviruses of serotypes 1, 2 and 3.
Minor PD; Ferguson M; Evans DM; Almond JW; Icenogle JP
J Gen Virol; 1986 Jul; 67 ( Pt 7)():1283-91. PubMed ID: 2425046
[TBL] [Abstract][Full Text] [Related]
4. Identification of the location of antigenic sites of swine vesicular disease virus with neutralization-resistant mutants.
Kanno T; Inoue T; Wang Y; Sarai A; Yamaguchi S
J Gen Virol; 1995 Dec; 76 ( Pt 12)():3099-106. PubMed ID: 8847515
[TBL] [Abstract][Full Text] [Related]
5. N-AgIB of poliovirus type 1: a discontinuous epitope formed by two loops of VP1 comprising residues 96-104 and 141-152.
Wiegers K; Uhlig H; Dernick R
Virology; 1989 Jun; 170(2):583-6. PubMed ID: 2471354
[TBL] [Abstract][Full Text] [Related]
6. Folding and processing of the capsid protein precursor P1 is kinetically retarded in neutralization site 3B mutants of poliovirus.
Reynolds C; Birnby D; Chow M
J Virol; 1992 Mar; 66(3):1641-8. PubMed ID: 1310770
[TBL] [Abstract][Full Text] [Related]
7. Identification of a new neutralization antigenic site on poliovirus coat protein VP2.
Emini EA; Jameson BA; Wimmer E
J Virol; 1984 Nov; 52(2):719-21. PubMed ID: 6208380
[TBL] [Abstract][Full Text] [Related]
8. Three-dimensional structure of poliovirus serotype 1 neutralizing determinants.
Page GS; Mosser AG; Hogle JM; Filman DJ; Rueckert RR; Chow M
J Virol; 1988 May; 62(5):1781-94. PubMed ID: 2451757
[TBL] [Abstract][Full Text] [Related]
9. The amino acid sequence of the outer coat protein VP2 of neutralizing monoclonal antibody-resistant, virulent and attenuated bluetongue viruses.
Gould AR; Eaton BT
Virus Res; 1990 Nov; 17(3):161-72. PubMed ID: 1706548
[TBL] [Abstract][Full Text] [Related]
10. Location and primary structure of a major antigenic site for poliovirus neutralization.
Minor PD; Schild GC; Bootman J; Evans DM; Ferguson M; Reeve P; Spitz M; Stanway G; Cann AJ; Hauptmann R; Clarke LD; Mountford RC; Almond JW
Nature; 1983 Feb; 301(5902):674-9. PubMed ID: 6186919
[TBL] [Abstract][Full Text] [Related]
11. Expression of a foreign epitope on the surface of the adenovirus hexon.
Crompton J; Toogood CI; Wallis N; Hay RT
J Gen Virol; 1994 Jan; 75 ( Pt 1)():133-9. PubMed ID: 7509367
[TBL] [Abstract][Full Text] [Related]
12. Differences in conformation of type 3 poliovirus antigenic sites on non-infectious empty particles and infectious virus.
Ferguson M; Minor PD
J Gen Virol; 1990 Jun; 71 ( Pt 6)():1271-4. PubMed ID: 1693661
[TBL] [Abstract][Full Text] [Related]
13. Addition of a foreign oligopeptide to the major capsid protein of poliovirus.
Colbère-Garapin F; Christodoulou C; Crainic R; Garapin AC; Candrea A
Proc Natl Acad Sci U S A; 1988 Nov; 85(22):8668-72. PubMed ID: 2460875
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Mengo virus neutralization epitopes.
Boege U; Kobasa D; Onodera S; Parks GD; Palmenberg AC; Scraba DG
Virology; 1991 Mar; 181(1):1-13. PubMed ID: 1704653
[TBL] [Abstract][Full Text] [Related]
15. Dynamics of Evolution of Poliovirus Neutralizing Antigenic Sites and Other Capsid Functional Domains during a Large and Prolonged Outbreak.
Shaw J; Jorba J; Zhao K; Iber J; Chen Q; Adu F; Adeniji A; Bukbuk D; Baba M; Henderson E; Dybdahl-Sissoko N; McDonald S; Weldon WC; Gumede N; Oberste MS; Kew OM; Burns CC
J Virol; 2018 May; 92(9):. PubMed ID: 29444940
[TBL] [Abstract][Full Text] [Related]
16. Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site.
Blondel B; Crainic R; Fichot O; Dufraisse G; Candrea A; Diamond D; Girard M; Horaud F
J Virol; 1986 Jan; 57(1):81-90. PubMed ID: 2416957
[TBL] [Abstract][Full Text] [Related]
17. Evolution of poliovirus during an outbreak: sequential type 3 poliovirus isolates from several persons show shifts of neutralization determinants.
Huovilainen A; Hovi T; Kinnunen L; Takkinen K; Ferguson M; Minor P
J Gen Virol; 1987 May; 68 ( Pt 5)():1373-8. PubMed ID: 2437244
[TBL] [Abstract][Full Text] [Related]
18. Identification of a T-cell epitope adjacent to neutralization antigenic site 1 of poliovirus type 1.
Leclerc C; Deriaud E; Mimic V; van der Werf S
J Virol; 1991 Feb; 65(2):711-8. PubMed ID: 1702841
[TBL] [Abstract][Full Text] [Related]
19. Sequence analysis of monoclonal antibody resistant mutants of type O foot and mouth disease virus: evidence for the involvement of the three surface exposed capsid proteins in four antigenic sites.
Kitson JD; McCahon D; Belsham GJ
Virology; 1990 Nov; 179(1):26-34. PubMed ID: 1699353
[TBL] [Abstract][Full Text] [Related]
20. Analysis of neutralization-escape mutants selected from a mouse virulent type 1/type 2 chimeric poliovirus: identification of a type 1 poliovirus with antigenic site 1 deleted.
Couderc T; Martin A; Wychowski C; Girard M; Horaud F; Crainic R
J Gen Virol; 1991 Apr; 72 ( Pt 4)():973-7. PubMed ID: 1707949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
